PTPI · Categories · Form 4
PTPI - SEC Form 4 insider transactions
Petros Pharmaceuticals Inc. (PTPI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for PTPI
- Officer Boctor Fady was granted 375,000 shares, increasing direct ownership by 72% to 894,986 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Director Bernstein Bruce was granted 1,875,000 shares, increasing direct ownership by 99% to 3,762,334 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Director Silverman Joshua was granted 4,375,000 shares, increasing direct ownership by 99% to 8,790,450 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Officer Boctor Fady was granted 500,000 shares, increasing direct ownership by 2,502% to 519,986 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Director Silverman Joshua was granted 4,375,000 shares, increasing direct ownership by 10,816% to 4,415,450 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Director Walker Wayne Remell was granted 500,000 shares, increasing direct ownership by 7,895% to 506,333 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Director Bernstein Bruce was granted 1,875,000 shares, increasing direct ownership by 15,202% to 1,887,334 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Director Walker Wayne Remell was granted 150,000 shares, increasing direct ownership by 1,804% to 158,314 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Officer Arnold Mitchell was granted 150,000 shares (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Director Silverman Joshua was granted 1,000,000 shares, increasing direct ownership by 8,899% to 1,011,237 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Officer Boctor Fady was granted 450,000 shares, increasing direct ownership by 906% to 499,645 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Director Bernstein Bruce was granted 300,000 shares, increasing direct ownership by 3,595% to 308,346 units (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bernstein Bruce4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- Boctor Fady was granted 49,645 shares (SEC Form 4)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Walker Wayne Remell4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Arnold Mitchell4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Silverman Joshua4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bradley Greg4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bradley Greg4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bernstein Bruce4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Walker Wayne Remell4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Silverman Joshua4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Walker Wayne Remell4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Silverman Joshua4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bradley Greg4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bernstein Bruce4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4: Walker Wayne Remell converted options into 2,264 shares4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4: Silverman Joshua converted options into 2,515 shares, increasing direct ownership by 126% to 4,515 units4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4: Bradley Greg converted options into 2,264 shares4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4: Bernstein Bruce converted options into 2,264 shares, increasing direct ownership by 7,075% to 2,296 units4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Walker Wayne Remell4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Silverman Joshua4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bradley Greg4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bernstein Bruce4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Walker Wayne Remell4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Silverman Joshua4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bradley Greg4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bernstein Bruce4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4: Shulman John D bought $500,001 worth of shares (145,773 units at $3.43)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4: Shulman John D bought $1,500,000 worth of shares (500,000 units at $3.00)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4: Shulman John D bought $2,849,999 worth of shares (1,661,807 units at $1.72)4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Metuchen Therapeutics, Llc4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Gesek Andrew4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Arnold Mitchell4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by D John Shulman4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Greg Bradley4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Remell Wayne Walker4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Bruce Bernstein4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Joshua Silverman4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)
- SEC Form 4 filed by Fady Boctor4 - Petros Pharmaceuticals, Inc. (0001815903) (Issuer)